Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

Share Price is delayed by 15 minutes
Get Live Data
1,913.00    -25.00 (-1.29%)
Bid:
1,917.00
Ask:
1,918.00
Spread: 1.00 (0.052%)
Market Cap: £76.72b
GSK Live PriceLast checked at - London Stock Exchange

Intraday Glaxosmithkline Share Chart

Glaxosmithkline News

Mandelson's consultancy firm set to enter administration after Epstein links
19 Feb 2026

Mandelson's consultancy firm set to enter administration after Epstein links

LONDON, Feb 19 (Reuters) - ​Global Counsel, the consultancy firm co-founded by former British ambassador to the United States Peter ​Mandelson, ‌is pr...

GSK starts GBP450 million buyback tranche as EU approves Exdensur drug
17 Feb 2026

GSK starts GBP450 million buyback tranche as EU approves Exdensur drug

(Alliance News) - GSK PLC on Tuesday announced the beginning of the fourth tranche of a GBP2 billion buyback programme, worth GBP450 million.

LONDON BROKER RATINGS: Peel Hunt cuts InterContinental Hotels - 'hold'
17 Feb 2026

LONDON BROKER RATINGS: Peel Hunt cuts InterContinental Hotels - 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and on Monday:

GSK's Exdensur gets green light from European Commission
17 Feb 2026

GSK's Exdensur gets green light from European Commission

(Sharecast News) - Drugmaker GSK said on Tuesday that the European Commission has approved its asthma and nasal polyps treatment Exdensur (depemokimab...

LONDON BROKER RATINGS: Bernstein, Barclays and Deutsche lower Relx
13 Feb 2026

LONDON BROKER RATINGS: Bernstein, Barclays and Deutsche lower Relx

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and on Thursday:

LONDON BRIEFING: NatWest results ahead of forecasts, ups dividend 51%
13 Feb 2026

LONDON BRIEFING: NatWest results ahead of forecasts, ups dividend 51%

(Alliance News) - NatWest beats annual earnings expectations and boosts shareholder returns, while AstraZeneca reports positive late-stage trial data ...

Sanofi ousts CEO Hudson after stalled turnaround at vaccine giant
12 Feb 2026

Sanofi ousts CEO Hudson after stalled turnaround at vaccine giant

LONDON, Feb 12 (Reuters) - French drugmaker Sanofi ousted CEO Paul Hudson on Thursday, ending a ​six-year tenure ‌marked by a stalled drive to replace...